I have one of the best post-transplant coordinators, Nurse Rachel Abarca. I’m so grateful for the excellent nurses on 10-2, 10-3, and beyond at Mayo Clinic. Mayo Clinic Transplant Even had a few from St. Scholastica !

Now published in HEPATOLOGY Journal: This AASLD Practice Guidance provides an updated approach to the prevention, diagnosis, and treatment of hepatocellular carcinoma (HCC). bit.ly/3ZcZySg #LiverTwitter

Rising alcohol-associated liver disease–related mortality rates in the United States from 1999 to 2022 Evidence Corner by: Sebastian Niezen MD, MMSc journals.lww.com/hepcomm/fullte…

November is #StomachCancerAwarenessMonth, and experts at Mayo Clinic say there is hope for patients with the disease as treatments continue to improve. mayocl.in/47I2Hg3

Mayo Clinic embarks on a $5 billion project to revolutionize its flagship medical campus in #RochMN. Five new buildings will fuse traditional medical services with AI and digital tools, creating a 21st-century vision of clinical care. bit.ly/3uE2Wuk STAT

The AASLD Transplant Hepatology Fellowship Matching Program is open for applications. Mayo Clinic in Rochester, MN is looking to match 4 exceptional individuals into our training program. Apply here: aasldapp.org

Editor-in-Chief Dr. Joseph K. Lim's editorial ClinicalLiverDisease Clinical Liver Disease: Legacy of innovation in hepatology education journals.lww.com/cld/fulltext/2…

Hepatocellular carcinoma screening is associated with reduced mortality even after accounting for lead-time & length-time biases, this study finds. ja.ma/3JEUDCM Amit G Singal Darine Daher @NDP1001 @drhuangdq Nicole Rich @kanwalfasiha anand kulkarni @bluefaeryliver

Sobering stats on early onset CRC.

Critical review alert 🚨🚨🚨 Cirrhotic cardiomyopathy and future directions Led by Dr. Cirrhotic cardiomyopathy himself - Manhal Izzy journals.lww.com/lt/abstract/99…

Course co-director, Dr. Mike Leise, presenting pearls about hepatic encephalopathy at the Mayo Clinic Gastroenterology & Hepatology #BoardReview course in Chicago

Mayo Clinic in Rochester is once again ranked #1 in the most specialties (7) on Newsweek's World's Best Specialized Hospitals 2025 list: bit.ly/4gwt3GO

Sharing our recent paper in BMJ Open Quality. We improved 1 year post-transplant outcomes Mayo Clinic Transplant, addressing the programmatic risk and "last case bias". bmjopenquality.bmj.com/content/14/1/e… Thank you Will Sanchez, MD | Hepatologist, Timucin Taner, for your mentorship! University Hospitals CWRU School of Medicine

Mayo Clinic hospitals in Arizona, Florida, and Minnesota have once again been recognized by Healthgrades as part of their 2025 America's 50 Best Hospitals list. Learn more: mayocl.in/40CUGak

For the 7th year in a row, Newsweek named Mayo Clinic the World’s Best Hospital! This honor is possible because of our dedicated staff, who make excellence the standard every day. Hear from our team on what this means to them. bit.ly/4kPAT0w

🚨 Reminder: The 2025 NHHF Health Professional Student Scholarship is OPEN! For full-time students in medicine, dentistry, pharmacy, nursing (incl. BSN), PA, & public health. 🗓️ Deadline: Aug 15 Apply here: app.smarterselect.com/programs/10287…

More than three years after a liver transplant, Jessie Boyd is living life to the fullest and has returned to teaching.⁠ Watch a lovely "thank you" message from Jessie to her donor and her Mayo care team.⁠ ⁠ Read more of Jessie’s story: mayocl.in/3TBkmRB

Innovations in Gastroenterology and Hepatology 2026: AI & Beyond will highlight promising developments ranging from endoscopy techniques to AI tools for diagnosis & management of GI and hepatobiliary diseases. Jan. 16-17 in Arizona & via livestream. mayocl.in/4eOfbqZ

35 years ago, Mayo Clinic Gastroenterology and Hepatology was named #1 in specialty Gastroenterology care. Today, we are proud to be #1 again, for the 35th year in a row! We could not be #1 without the dedication and excellence from our staff, nor without the support from our

MASLD has become the most common chronic liver disease worldwide. Giovanni Targher, MD, Luca Valenti, MD (Luca Valenti), and Christopher D. Byrne, MB, ChB, review the features of the disease as well as pharmacotherapies targeting the associated liver and